Harbour BioMed
Year founded
-
Country of origin
China
HQ country
China
Total deal value
Average deal value
Company industry
- Medical & Biotech
M&A expertise
- -
Industry expertise
- Medical & Biotech
Harbour BioMed was established in 2016 with an initial financing of USD 50m from Advantech Capital, Legend Capital and the Harbour BioMed founding team. The company is headquartered with R&D operations in Shanghai, business operations in Cambridge, MA, and antibody platform innovation operations in Rotterdam, The Netherlands.